Taysha Gene Therapies (TSHA) PT Raised to $10 at BMO Capital
Tweet
Share
E-mailGet Alerts TSHA Hot Sheet
Price: $6.42 +3.72%
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Join SI Premium – FREE
BMO Capital analyst Evan Seigerman raised the price target on Taysha Gene Therapies (NASDAQ: TSHA) to $10.00 (from $8.00) while maintaining a Outperform rating.
You May Also Be Interested In
- JPMorgan Upgrades YDUQS Participacoes SA (YDUQ3:BZ) to Overweight
- Douglas AG (DOU:GR) PT Lowered to EUR9 at Goldman Sachs
- UBS Upgrades Bystronic AG (BYS:SW) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
